发明名称 Use of fumaric acid derivatives for treatment of an auto-immune disease
摘要 The use of one or several compounds selected from the group of sodium, potassium, calcium, magnesium, zinc and iron salts of fumeric acid monoalkyl esters of formula (1), optionally in combination with dialkyl fumerate of formula (2) wherein; A is a bivalent cation from the series containing Ca, Mg, Zn, or Fe or a monovalent cation from the series consisting of potassium or sodium respectively, and n denotes the numeral 1 or 2 depending on the type of cation, or one or several of the compounds from the series consisting of alkyl hydrogen fumerates formula (3), optionally in combination with dialkyl fumerate of formula (4), in pharmaceutical compositions. The compositions is useful in treating auto-immune diseases selected from the group consisting of polyarthritis, multiple sclerosis, graft-versus-host reactions, juvenile diabetes, Hashimoto tyroiditis, Grave's diseases, systemic Lupus erythaematodes (SLE), Sjogren's Syndrome, pernicious anaemia and chronic active (lupoid) hepatitis.
申请公布号 NZ501755(A) 申请公布日期 2001.07.27
申请号 NZ19980501755 申请日期 1998.04.01
申请人 FUMAPHARM AG 发明人 JOSHI, RAJENDRA KUMAR;STREBEL, HANS-PETER
分类号 A61P9/02;A61K31/22;A61K31/225;A61K31/295;A61K31/315;A61P37/00;A61P37/06;C07C69/60;(IPC1-7):A61K31/19 主分类号 A61P9/02
代理机构 代理人
主权项
地址
您可能感兴趣的专利